IBDEI0W5 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15074,1,4,0)
 ;;=4^E11.51
 ;;^UTILITY(U,$J,358.3,15074,2)
 ;;=^5002650
 ;;^UTILITY(U,$J,358.3,15075,0)
 ;;=E11.52^^56^638^12
 ;;^UTILITY(U,$J,358.3,15075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15075,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Peripheral Angiopathy w/ Gangrene
 ;;^UTILITY(U,$J,358.3,15075,1,4,0)
 ;;=4^E11.52
 ;;^UTILITY(U,$J,358.3,15075,2)
 ;;=^5002651
 ;;^UTILITY(U,$J,358.3,15076,0)
 ;;=E11.621^^56^638^14
 ;;^UTILITY(U,$J,358.3,15076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15076,1,3,0)
 ;;=3^DM Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,15076,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,15076,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,15077,0)
 ;;=E11.641^^56^638^16
 ;;^UTILITY(U,$J,358.3,15077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15077,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,15077,1,4,0)
 ;;=4^E11.641
 ;;^UTILITY(U,$J,358.3,15077,2)
 ;;=^5002661
 ;;^UTILITY(U,$J,358.3,15078,0)
 ;;=E11.649^^56^638^17
 ;;^UTILITY(U,$J,358.3,15078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15078,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,15078,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,15078,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,15079,0)
 ;;=H40.11X0^^56^639^9
 ;;^UTILITY(U,$J,358.3,15079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15079,1,3,0)
 ;;=3^Glaucoma,Primary Open-Angle,Unspec Stage
 ;;^UTILITY(U,$J,358.3,15079,1,4,0)
 ;;=4^H40.11X0
 ;;^UTILITY(U,$J,358.3,15079,2)
 ;;=^5005753
 ;;^UTILITY(U,$J,358.3,15080,0)
 ;;=H40.11X1^^56^639^6
 ;;^UTILITY(U,$J,358.3,15080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15080,1,3,0)
 ;;=3^Glaucoma,Primary Open-Angle,Mild Stage
 ;;^UTILITY(U,$J,358.3,15080,1,4,0)
 ;;=4^H40.11X1
 ;;^UTILITY(U,$J,358.3,15080,2)
 ;;=^5005754
 ;;^UTILITY(U,$J,358.3,15081,0)
 ;;=H40.11X2^^56^639^7
 ;;^UTILITY(U,$J,358.3,15081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15081,1,3,0)
 ;;=3^Glaucoma,Primary Open-Angle,Moderate Stage
 ;;^UTILITY(U,$J,358.3,15081,1,4,0)
 ;;=4^H40.11X2
 ;;^UTILITY(U,$J,358.3,15081,2)
 ;;=^5005755
 ;;^UTILITY(U,$J,358.3,15082,0)
 ;;=H40.11X3^^56^639^8
 ;;^UTILITY(U,$J,358.3,15082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15082,1,3,0)
 ;;=3^Glaucoma,Primary Open-Angle,Severe Stage
 ;;^UTILITY(U,$J,358.3,15082,1,4,0)
 ;;=4^H40.11X3
 ;;^UTILITY(U,$J,358.3,15082,2)
 ;;=^5005756
 ;;^UTILITY(U,$J,358.3,15083,0)
 ;;=H40.11X4^^56^639^5
 ;;^UTILITY(U,$J,358.3,15083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15083,1,3,0)
 ;;=3^Glaucoma,Primary Open-Angle,Indeterminate Stage
 ;;^UTILITY(U,$J,358.3,15083,1,4,0)
 ;;=4^H40.11X4
 ;;^UTILITY(U,$J,358.3,15083,2)
 ;;=^5005757
 ;;^UTILITY(U,$J,358.3,15084,0)
 ;;=H11.33^^56^639^2
 ;;^UTILITY(U,$J,358.3,15084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15084,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Bilateral
 ;;^UTILITY(U,$J,358.3,15084,1,4,0)
 ;;=4^H11.33
 ;;^UTILITY(U,$J,358.3,15084,2)
 ;;=^5004784
 ;;^UTILITY(U,$J,358.3,15085,0)
 ;;=H11.31^^56^639^4
 ;;^UTILITY(U,$J,358.3,15085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15085,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Right Eye
 ;;^UTILITY(U,$J,358.3,15085,1,4,0)
 ;;=4^H11.31
 ;;^UTILITY(U,$J,358.3,15085,2)
 ;;=^5004782
 ;;^UTILITY(U,$J,358.3,15086,0)
 ;;=H11.32^^56^639^3
 ;;^UTILITY(U,$J,358.3,15086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15086,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Left Eye
 ;;^UTILITY(U,$J,358.3,15086,1,4,0)
 ;;=4^H11.32
 ;;^UTILITY(U,$J,358.3,15086,2)
 ;;=^5004783
 ;;^UTILITY(U,$J,358.3,15087,0)
 ;;=H61.23^^56^639^13
 ;;^UTILITY(U,$J,358.3,15087,1,0)
 ;;=^358.31IA^4^2
